Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07649031 · ClinicalTrials.gov registry record
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
A clinical trial, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 80
- Enrollment target
NCT07649031 is a clinical trial that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 80 participants.
The verdict
NCT07649031 is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Interventions
- DIAGNOSTIC_TEST MRIs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2030-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07649031
The ClinicalTrials.gov registry entry for NCT07649031 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRIs is the first listed.
NCT07649031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07649031 about?
NCT07649031 is a clinical study titled "MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients". This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
What is the current status of trial NCT07649031?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2026-06-23. Estimated completion is 2030-05-31.
What interventions are being tested in trial NCT07649031?
The interventions under investigation include: MRIs (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07649031?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.